Javascript er ikke aktivert i din nettleser. Dette er nødvendig for å bruke Oncolex. Kontakt din systemadministrator for å aktivere JavaScript.

Treatment of Hodgkin's lymphoma

It is important that treatment follows the recommended intervals. If these intervals cannot he upheld, for example due to neutropenia, bone marrow stimulating growth factor (G-CSF) can stimulate the bone marrow to reach an acceptable level before each planned course of chemotherapy. 

Surgery is rarely indicated for Hodgkin's lymphoma.

Curing the disease is still possible after recurrence, and in some cases, after later recurrences. The prognosis of patients with recurrence is better if the relapse develops late after completion of the primary treatment. If recurrence occurs outside the radiation field where radiotherapy was the only primary treatment modality, the prognosis is almost as good as at the time of diagnosis. It is important that the role of radiation therapy in treatment of recurrence is evaluated before chemotherapy begins.

Responsibility for treatment of Hodgkin's lymphoma is centralized to the university hospitals.


Oslo University Hospital shall not be liable for any loss whether direct, indirect, incidental or consequential, arising out of access to, use of, or reliance upon any of the content on this website. Oslo University Hospital© 2018